Table 1 VEGF concentrations obtained for the positive and negative controls for the 11 series performed to validate the VEGF quantification method in patient supernatants using the ELLA system and its VEGF cartridge, four series to assess the linearity parameter and six for the precision. *Indicates that concentration is out of range.
From: Validation of a potency assay for CD34 + cell based therapy
Series | Positive control high | Positive control low | Negative control | ||
|---|---|---|---|---|---|
Range 1108–2274 pg/mL | Range 24.4–42.0 pg/mL | < LLOQ | |||
Linearity Data | Day 1 | Serie 1a | 1482 | 31 | 1* |
Serie 1b | 1630 | 32 | 1* | ||
Serie 1c | 1491 | 30 | 0* | ||
Day 2 | Serie 2 | 1495 | 29 | 1* | |
Serie 3 | 1557 | 31 | 1* | ||
Precision Data | Day 1 | Serie 1 | 1559 | 31 | 0* |
Serie 4 | 1572 | 32 | 0* | ||
Day 2 | Serie 2 | 1270 | 28 | 1* | |
Serie 5 | 1330 | 27 | 2* | ||
Day 3 | Serie 3 | 1602 | 33 | 2* | |
Serie 6 | 1941 | 35 | 2* | ||